Literature DB >> 8467567

Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population.

A O Adebajo1, P Charles, R N Maini, B L Hazleman.   

Abstract

Following reports of associations between autoantibodies and living in the tropics, we have studied the seroprevalence and nature of anti-nuclear antibodies, anti-cardiolipin antibodies, antibodies to extractable nuclear antigens and anti-neutrophilic cytoplasmic antibodies in 351 West Africans with malaria, tuberculosis or hepatitis B, or in good health. Amongst healthy West Africans we found a seroprevalence of 7% for anti-nuclear antibodies with several staining patterns, and of 30.3% for anti-cardiolipin antibodies. Among patients with tuberculosis and malaria there was twice that frequency of anti-nuclear antibodies (predominantly speckled in pattern), and anti-neutrophil cytoplasmic antibodies (predominantly IgM) were demonstrated in a few cases. A possible association between IgG anti-cardiolipin antibodies and tuberculosis was observed (P < 0.05), but antibodies to double-stranded DNA were not elevated and no antibodies to extractable nuclear antigens were found in any of the patients or healthy individuals studied. Our findings suggest the need for caution in the interpretation of autoantibody tests in subjects from or living in the tropics, as well as in patients with tropical infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467567      PMCID: PMC1554859          DOI: 10.1111/j.1365-2249.1993.tb05950.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  TROPICAL HYPERGAMMAGLOBULINAEMIA AND TISSUE ANTIBODIES.

Authors:  C C CURTAIN; C KIDSON; J G GORMAN; D PARKINSON
Journal:  Trans R Soc Trop Med Hyg       Date:  1965-07       Impact factor: 2.184

2.  Autoimmune and polyclonal B cell responses during murine malaria.

Authors:  Y J Rosenberg
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

3.  Serological indices in Tanzania. II. Antinuclear factor and malarial indices in populations living at different altitudes.

Authors:  A Voller; P O'Neill; D Humphrey
Journal:  J Trop Med Hyg       Date:  1972-07

4.  Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda.

Authors:  A G Shaper; M H Kaplan; N J Mody; P A McIntyre
Journal:  Lancet       Date:  1968-06-22       Impact factor: 79.321

5.  Cold haemagglutinins associated with splenomegaly in New Guinea.

Authors:  W R Pitney; H N Thomas; J V Wells
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

6.  Autoantibodies in falciparum malaria: a sequential study in 183 Thai patients.

Authors:  P Phanuphak; S Tirawatnpong; M Hanvanich; W Panmuong; P Moollaor; S Vejjajiva; V Sitprija; R Intaraprasert; D Phanthumkosol
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  J R Chapman; P J Charles; P J Venables; P J Thompson; P L Haslam; R N Maini; M E Turner Warwick
Journal:  Am Rev Respir Dis       Date:  1984-09

8.  Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.

Authors:  T Koike; H Tomioka; A Kumagai
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

9.  Speckled antinuclear factor in African sera.

Authors:  B M Greenwood; E M Herrick; E J Holborow
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

10.  Anti-ssDNA and antinuclear antibodies in human malaria.

Authors:  D Adu; D G Williams; I A Quakyi; A Voller; Y Anim-Addo; A A Bruce-Tagoe; G D Johnson; E J Holborow
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

View more
  19 in total

1.  Effects of anti-endothelial cell antibodies in leprosy and malaria.

Authors:  Christophe Dugué; Ronald Perraut; Pierre Youinou; Yves Renaudineau
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis.

Authors:  O Elkayam; R Segal; M Lidgi; D Caspi
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

Review 3.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria.

Authors:  C Wenisch; H Wenisch; H C Bankl; M Exner; W Graninger; S Looareesuwan; H Rumpold
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 6.  Cardiolipin, coagulation, co-factors and connective tissue disease.

Authors:  R S Pereira
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 7.  Tuberculosis and Autoimmunity.

Authors:  Irina V Belyaeva; Anna N Kosova; Andrei G Vasiliev
Journal:  Pathophysiology       Date:  2022-06-13

8.  Background noise of infection for using ANCA as a diagnostic tool for vasculitis in tropical and developing countries.

Authors:  Kanjaksha Ghosh; Vandana Pradhan; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2008-02-24       Impact factor: 2.289

9.  Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia?

Authors:  D Blockmans; E Stevens; G Mariën; H Bobbaers
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

10.  The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis.

Authors:  Ori Elkayam; Daniele Bendayan; Refael Segal; Yinon Shapira; Boris Gilburd; Sandra Reuter; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2012-08-04       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.